跳转至内容
Merck
CN

T-077

3,3′,5-三碘-L-甲状腺素-13C6 溶液

100 μg/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material, Cerilliant®

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
13C6C9H12I3NO4
化学文摘社编号:
分子量:
656.93
NACRES:
NA.24
UNSPSC Code:
41116107
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

3,3′,5-三碘-L-甲状腺素-13C6 溶液, 100 μg/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material, Cerilliant®

InChI

1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1/i3+1,4+1,7+1,10+1,11+1,14+1

InChI key

AUYYCJSJGJYCDS-HRUXDFQWSA-N

SMILES string

IC1=CC(O[13C]2=[13C](I)[13CH]=[13C](C[C@H](N)C(O)=O)[13CH]=[13C]2I)=CC=C1O

grade

certified reference material

form

liquid

feature

(Snap-N-Spike®)

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

100 μg/mL in methanol with 0.1N NH3

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

−20°C

Quality Level

General description

内标3,3´,5--三碘-L-甲状腺原氨酸--13C6(T3-13C6)的Certified Spiking Solution®。3,3′,5-三碘-L-甲状腺原氨酸(T3)是一种甲状腺激素,参与人体生长发育、代谢、体温和心率等多种生理过程。该内标适用于LC-MS/MS法定量检测血清游离T3和总T3水平,以测定由过量T3引起的甲亢。

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

存储类别

3 - Flammable liquids

wgk

WGK 2

flash_point_f

49.5 °F

flash_point_c

9.7 °C

法规信息

危险化学品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Christina Stefanaki et al.
The Journal of dermatological treatment, 26(2), 139-142 (2014-05-20)
All available treatments for anogenital warts have substantial failure rates. An immunomodulating treatment that enhances the patient's own immunity could be valuable as an adjuvant to conventional methods. About 123 patients were enrolled in this study and were randomized either
Henry Buchwald et al.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 10(5), 780-786 (2014-05-20)
We do not have a unified, scientifically tested theory of causation for obesity and its co-morbidities, nor do we have explanations for the mechanics of the metabolic/bariatric surgery procedures. Integral to proffered hypotheses are the actions of the hormones glucagon-like
Angie Tong et al.
Psycho-oncology, 24(1), 33-39 (2014-05-20)
Genetic testing for breast and ovarian cancer susceptibility is now part of routine clinical practice. Although rates of risk-reducing surgery following genetic testing have been increasing, little is known about attitudes toward risk-reducing surgery in women prior to genetic counseling
Nadine Tung et al.
Breast cancer research and treatment, 146(1), 175-182 (2014-05-20)
The majority of breast cancers developing in BRCA1 mutation carriers are triple negative breast cancers (TNBC), an aggressive subtype that accounts for 15-20 % of sporadic breast cancer. We compare the clinical outcome and sites of relapse of TNBC in BRCA1
Avantika Gupta et al.
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 30(2), 120-125 (2014-05-20)
The aim of this study was to compare the efficacy and safety of intravenous iron sucrose with oral iron therapy in pregnant patients with anemia. The primary outcome of the study was increase in haemoglobin on day 7, 14 &

商品

Determination of free thyroid hormones (T3 & T4) in serum by LC-MS/MS following a streamlined 1-hour BioSPME sample preparation.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持